|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | |
| A61P 35/00 | |||
| A61P 43/00 | |||
| A61K 47/68 | |||
| A61K 39/00 | |||
| A61N 5/10 |
| (11) | Number of the document | 3409287 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18171803.2 |
| Date of filing the European patent application | 2011-09-29 | |
| (97) | Date of publication of the European application | 2018-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 38793310 P | 2010-09-29 | US |
| (72) |
SATPAEV, Daulet, US
MORRISON, Robert Kendall, US
MORRISON, Karen Jane Meyrick, US
GUDAS, Jean, US
JAKOBOVITS, Aya, US
TORGOV, Michael, US
AN, Zili, US
|
| (73) |
Agensys, Inc.,
1800 Stewart Street, Santa Monica, CA 90404,
US
Seagen Inc., 21823 30th Drive, S.E., Bothell, WA 98021, US |
| (54) | ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS |
| ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS |